Status:
COMPLETED
A Clinical Trial Assessing the Impact of the Availability of Inhaled Insulin on Glucose Control
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Sanofi
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
35-80 years
Phase:
PHASE3
Brief Summary
To assess the impact on glucose control by inhaled insulin in patients with type 2 diabetes who are not well controlled on 2 or more oral anti-diabetic agents
Eligibility Criteria
Inclusion
- Diabetes mellitus Type 2
- Failing two or more oral anti-diabetic agents
Exclusion
- Asthma, COPD
- Smoking
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
1100 Patients enrolled
Trial Details
Trial ID
NCT00134147
Start Date
April 1 2005
End Date
May 1 2007
Last Update
April 17 2008
Active Locations (121)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
La Jolla, California, United States, 92037
2
Pfizer Investigational Site
San Diego, California, United States, 92128
3
Pfizer Investigational Site
Washington D.C., District of Columbia, United States, 20010
4
Pfizer Investigational Site
Jacksonville, Florida, United States, 32208